{"database": "lobbying", "table": "lobbying_activities", "rows": [[2470982, "53638916-aa3f-4a4c-9416-a79542824cf2", "Q2", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2020, "second_quarter", "PHA", "H.R. 1781 - Payment Commission Data Act of 2019\nH.R. 938 - the BLOCKING Act of 2019\nH.R. 1520 - the Purple Book Continuity Act of 2019\nH.R. 1503 - the Orange Book Transparency Act of 2019\nH.R. 1499 - Protecting Consumer Access to Generic Drugs Act of 2019\nH.R. 965 - the CREATES Act of 2019\nS. 1895 - Lower Health Care Costs Act\nS. 1416 - Affordable Prescriptions For Patients Act of 2019 \nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\nS. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act\nS. 3129 - Lower Costs, More Cures Act of 2019\n\n\nno specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 80000, null, 0, 0, "2020-07-17T10:58:55.060000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2470982"], "units": {}, "query_ms": 0.3451190423220396, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}